We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

199 hedge funds and large institutions have $1.06B invested in Editas Medicine in 2018 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 53

20% more call options, than puts

Call options by funds: $25.2M | Put options by funds: $20.9M

1.61% more ownership

Funds ownership: 68.05% → 69.66% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less funds holding

Funds holding: 215 → 199 (-16)

8% less capital invested

Capital invested by funds: $1.15B → $1.06B (-$94.5M)

33% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 42

Holders
199
Holders Change
-16
Holders Change %
-7.44%
% of All Funds
4.55%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
66
Reduced
53
Closed
42
Calls
$25.2M
Puts
$20.9M
Net Calls
+$4.22M
Net Calls Change
-$9M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$19.8M
2
VCM
Valiant Capital Management
California
+$12.3M
3
State Street
State Street
Massachusetts
+$10.6M
4
Renaissance Technologies
Renaissance Technologies
New York
+$9.7M
5
CC
Casdin Capital
New York
+$9.1M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$44.3M
2
Morgan Stanley
Morgan Stanley
New York
-$10.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$5.09M
4
Capital World Investors
Capital World Investors
California
-$4.91M
5
PIMJS
PKO Investment Management Joint-Stock
Poland
-$4.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$6.46M +$6.56M +202,874 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$6.33M +$180K +5,579 +3%
UBS AM
28
UBS AM
Illinois
$6.32M -$13.8K -427 -0.2%
WCM
29
Wildcat Capital Management
New York
$5.91M – – –
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$5.32M -$618K -19,125 -10%
TCIM
31
TIAA CREF Investment Management
New York
$5.01M -$257K -7,950 -5%
Capital International Investors
32
Capital International Investors
California
$4.84M +$4.91M +152,000 New
PAMU
33
Pictet Asset Management (UK)
United Kingdom
$4.69M +$1.35M +41,777 +40%
Handelsbanken Fonder
34
Handelsbanken Fonder
Sweden
$4.3M +$485K +15,000 +13%
UBS Group
35
UBS Group
Switzerland
$4.14M +$1.17M +36,103 +38%
First Trust Advisors
36
First Trust Advisors
Illinois
$3.9M +$924K +28,596 +30%
CAI
37
Capital Advisors Inc
Oklahoma
$3.87M +$65K +2,013 +2%
Hudson Bay Capital Management
38
Hudson Bay Capital Management
Connecticut
$3.5M +$323K +10,000 +10%
PP
39
PDT Partners
New York
$3.13M -$1.7M -52,638 -35%
Point72 Asset Management
40
Point72 Asset Management
Connecticut
$3.1M +$3.15M +97,400 New
EWM
41
Elmwood Wealth Management
California
$2.99M -$295K -9,124 -9%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$2.77M +$51.7K +1,600 +2%
WM
43
WS Management
Florida
$2.76M – – –
CAG
44
Crestwood Advisors Group
Massachusetts
$2.71M – – –
Allianz Asset Management
45
Allianz Asset Management
Germany
$2.62M -$2.41M -74,590 -48%
FT
46
Fiduciary Trust
Massachusetts
$2.45M – – –
TCM
47
Tekla Capital Management
Massachusetts
$2.44M -$1.98M -61,133 -44%
GIM
48
Granahan Investment Management
Massachusetts
$2.42M -$48.4K -1,498 -2%
GC
49
Guggenheim Capital
Illinois
$2.29M +$156K +4,827 +7%
Nisa Investment Advisors
50
Nisa Investment Advisors
Missouri
$2.27M +$3.56K +110 +0.2%
1
2
3 4 5

EDIT Hedge Fund Activity: Q3 2018 in Review

199 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2018, worth a combined $1.06B — down 8.2% from $1.15B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of EDIT and 28 opened new positions — a net loss of 14 holders — while 53 trimmed existing stakes and 66 added.

The largest buyer was ARK Investment Management, adding an estimated $19.8M. The largest seller was Fidelity Investments, cutting an estimated $44.3M.

  • 199 institutional investors held Editas Medicine (EDIT) as of Q3 2018, down from 215 in Q2 2018.
  • Funds reported $1.06B of Editas Medicine stock for Q3 2018, down 8.2% quarter-over-quarter.
  • 28 funds opened new Editas Medicine positions in Q3 2018 and 42 closed out, a net change of -14 holders.
  • The largest Editas Medicine buyer in Q3 2018 was ARK Investment Management, an estimated $19.8M added.
  • The largest Editas Medicine seller in Q3 2018 was Fidelity Investments, an estimated $44.3M sold.

Based on aggregated 13F filings for Q3 2018.